 |
PDBsum entry 3lau
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of aurora2 kinase in complex with a gsk3beta inhibitor
|
|
Structure:
|
 |
Serine/threonine-protein kinase 6. Chain: a. Fragment: unp residues 125-399. Synonym: aurora kinase a, aurora-a, serine/threonine kinase 15, aurora/ipl1-related kinase 1, aurora-related kinase 1, hark1, breast tumor-amplified kinase. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: aik, ark1, aura, aurka, btak, stk15, stk6. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.203
|
R-free:
|
0.248
|
|
|
Authors:
|
 |
S.Maignan,J.P.Guilloteau,S.Pouzieux
|
|
Key ref:
|
 |
D.Lesuisse
et al.
(2010).
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
Bioorg Med Chem Lett,
20,
1985-1989.
PubMed id:
|
 |
|
Date:
|
 |
|
07-Jan-10
|
Release date:
|
02-Mar-10
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O14965
(AURKA_HUMAN) -
Aurora kinase A from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
403 a.a.
251 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
20:1985-1989
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
|
|
D.Lesuisse,
G.Dutruc-Rosset,
G.Tiraboschi,
M.K.Dreyer,
S.Maignan,
A.Chevalier,
F.Halley,
P.Bertrand,
M.C.Burgevin,
D.Quarteronet,
T.Rooney.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
From an HTS hit, a series of potent and selective inhibitors of GSK3beta have
been designed based on a Cdk2-homology model and with the help of several
crystal structures of the compounds within Cdk2.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |